“Best Proposal in Medicine” award received by EORTC at the PTCOG 61 Conference
30 Jun 2023
EORTC is proud to announce that we have received an award as the “Best Proposal in Medicine” of the Particle Therapy Cooperation Group (PTCOG), recognising the importance of our upcoming 2024 workshop in the context of the H2020 project-HTx.
Since 2019, EORTC leads the Oncology Case Study of the H2020 project-HTx to deliver solutions to select patients with head and neck cancer who are most likely to benefit from proton therapy. We developed models that predict the likelihood for a particular patient to develop side effects (e.g. xerostomia/dysphagia) under photon-or proton-therapy. If prediction shows that proton therapy reduces the risk of side effects beyond a predefined clinically relevant threshold, the patient is selected to receive proton therapy. Meanwhile, we project this patient selection approach to a population level to see how much gain/loss the society would expect.
Proton therapy has been particularly applied to patients with head and neck cancer to reduce risks of treatment-related side effects such as dysphagia and xerostomia. As proton therapy is a resource-demanding treatment modality with limited capacity, it is crucial to identify patients who will benefit the most from proton therapy.
Dr. Lifang Liu, EORTC Scientific Lead of the project received the award during the PTCOG 61 Conference in Madrid, 10-16 June 2023:
“At EORTC, we have always put patients at the centre of all we do. This workshop represents precisely that principle: bringing science to the daily work of doctors and policymakers thereby supporting evidence-based decision-making and resulting in a better survival and quality of life for patients.”
Click here to learn more about EORTC’s involvement in the HTx Project Consortium.
Related News
Meet the new EORTC Board
9 Jul 2024
We are pleased to announce the release of the EORTC 2023 Annual Report
17 Jun 2024
Dr Denis Lacombe, EORTC CEO, appointed stakeholder co-chair of ACT EU advisory group
24 May 2024
Clinical Trials Day 2024: a Q&A on pragmatic clinical trials
20 May 2024
EORTC/EMA workshop suggests an international way forward for treatment optimisation studies
8 May 2024
EORTC’s Participation at the ESTRO Congress 2024
29 Apr 2024
EORTC: Advancing research and treatment for rare cancers
29 Feb 2024
EORTC Fellowship Programme: celebrating more than 20 years of impactful collaboration
22 Feb 2024
Appointment of Malte Peters as EORTC Strategic Alliance Officer
9 Feb 2024
Unique series of workshops in partnership with the European Medicines Agency (EMA)
7 Feb 2024